Health News (Reuters)

Russia reports severe bird flu outbreak: OIE

Russia has reported an outbreak of the highly pathogenic H5N2 bird flu virus on a farm in the Kostromskaya region in the west of the country, the World Organisation for Animal Health (OIE) said, citing a report from Russia's Agriculture Ministry.

Japan's Eisai sets price tag of about $16,000 on liver cancer drug

Japan's Eisai Co Ltd said on Thursday it would price its cancer drug Lenvima at about $16,000 for a month's supply before discounts, after the U.S. Food and Drug Administration approved its use in patients with a common form of liver cancer.

Links seen between asthma and ADHD

(Reuters Health) - There may be a strong connection between asthma and attention deficit hyperactivity disorder (ADHD) that makes people with one condition more likely to develop the other one, a recent study suggests.

Diet guidance could slow kidney disease, cut costs

(Reuters Health) - Patients with chronic kidney disease could slow the progression of their illness and delay dialysis through nutrition therapy, according to a new article in the Journal of the Academy of Nutrition and Dietetics.

FDA approves Teva's generic of Mylan's EpiPen

The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs.

Weight-loss surgery linked to better job prospects

(Reuters Health) - Obese adults who get surgery to lose weight may have an easier time getting a full-time job than they would without these operations, a French study suggests.

FDA approves first generic version of Mylan's EpiPen

The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's EpiPen for the emergency treatment of allergic reactions.

Trump administration seeks cuts in production of abused opioids

The Trump administration on Thursday said it was proposing that U.S. pharmaceutical companies cut production of the six most abused opioids by 10 percent next year, in an effort to reduce the number of drugs potentially diverted for trafficking.

Pages